nach oben

Current Anesthesiology Reports

Erschienen in:

01.12.2018 | Cancer Anesthesia (B Riedel and V Gottumukkala, Section Editors)

Cancer Biology: a Primer for Perioperative Clinicians

verfasst von: Jonathan A. Wilks

Erschienen in: Current Anesthesiology Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Cancer biology is a field that has grown exponentially in the last several decades. Elucidating the mechanisms involved in tumor development, while broadening our understanding, continues to reveal unexplained phenomena. Attempting to understand cancer biology requires a framework from which to start; two landmark reviews from 2000 and 2011 by Hanahan and Weinberg present such a framework. With advances in cancer therapeutics, an appreciation of the underlying tumor biology is necessary to optimally care for patients in the perioperative period.

•• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70 This is the intial systhesis by Hanahan and Weinberg describing the six hallmarks of cancer.PubMed

•• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74 The follow-up to their initial paper, Hanahan and Weinberg take a closer, updated, look at the six hallmarks of cancer and discuss the complicated relationships found in invasion and metastasis, inflammation, and immune avoidance.PubMed

•• Hiller JG, Perry NJ, Poulogiannis G, Riedel B, Sloan EK. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018;15(4):205–18 This excellent review examines the biological changes that occur during the perioperative period from the perspective of both the body's responses to surgery as well as the response to common anesthetic regimens.PubMed

Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235(4785):177–82.PubMed

Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159–70.PubMed

Davies MA, Samuels Y. Analysis of the genome to personalize therapy for melanoma. Oncogene. 2010;29(41):5545–55.PubMedPubMedCentral

Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749–59.PubMed

Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243(4893):934–7.PubMed

•• Bierie B, Moses HL. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer. 2006;6(7):506–20This review discusses the complexities of one molecule and the possible actions on tumor prevention/development.PubMed

10.

Iwasaki M, Zhao H, Jaffer T, Unwith S, Benzonana L, Lian Q, et al. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget. 2016;7(18):26042–56.PubMedPubMedCentral

11.

Kawaraguchi Y, Horikawa YT, Murphy AN, Murray F, Miyanohara A, Ali SS, et al. Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligandinduced apoptosis via caveolins. Anesthesiology. 2011;115(3):499–508.PubMed

12.

Wu GJ, Chen WF, Sung CS, Jean YH, Hung CH, Chen FA, et al. Isoflurane attenuates dynorphin-induced cytotoxicity and downregulation of Bcl-2 expression in differentiated neuroblastoma SH-SY5Y cells. Acta Anaesthesiol Scand. 2009;53(1):55–60.PubMed

13.

Du Q, Liu J, Zhang X, Zhang X, Zhu H, Wei M, et al. Propofol inhibits proliferation, migration, and invasion but promotes apoptosis by regulation of Sox4 in endometrial cancer cells. Braz J Med Biol Res. 2018;51(4):e6803.PubMedPubMedCentral

14.

Liu SQ, Zhang JL, Li ZW, Hu ZH, Liu Z, Li Y. Propofol Inhibits Proliferation, Migration, Invasion and Promotes Apoptosis Through Down-Regulating miR-374a in Hepatocarcinoma Cell Lines. Cell Physiol Biochem. 2018;49(6):2099–110.PubMed

15.

Shang Z, Feng H, Cui L, Wang W, Fu H. Propofol promotes apoptosis and suppresses the HOTAIR-mediated mTOR/p70S6K signaling pathway in melanoma cells. Oncol Lett. 2018;15(1):630–4.PubMed

16.

Yu B, Gao W, Zhou H, Miao X, Chang Y, Wang L, et al. Propofol induces apoptosis of breast cancer cells by downregulation of miR-24 signal pathway. Cancer Biomark. 2018;21(3):513–9.PubMed

17.

Zhang D, Zhou XH, Zhang J, Zhou YX, Ying J, Wu GQ, et al. Propofol promotes cell apoptosis via inhibiting HOTAIR mediated mTOR pathway in cervical cancer. Biochem Biophys Res Commun. 2015;468(4):561–7.PubMed

18.

Enlund M, Berglund A, Andreasson K, Cicek C, Enlund A, Bergkvist L. The choice of anaesthetic--sevoflurane or propofol--and outcome from cancer surgery: a retrospective analysis. Ups J Med Sci. 2014;119(3):251–61.PubMedPubMedCentral

19.

Lee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean J Anesthesiol. 2016;69(2):126–32.PubMedPubMedCentral

20.

•• Wigmore TJ, Mohammed K, Jhanji S. Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis. Anesthesiology. 2016;124(1):69–79 This retrospective study of over 7,000 patients finds a survival advantage in patients receiving TIVA compared to volatile agents.PubMed

21.

Lee SK, Dawson J, Lee JA, Osman G, Levitin MO, Guzel RM, et al. Management of cancer pain: 1. Wider implications of orthodox analgesics. Int J Gen Med. 2014;7:49–58.PubMedPubMedCentral

22.

Mahbuba W, Lambert DG. Opioids and neovascularization; pro or anti? Br J Anaesth. 2015;115(6):821–4.PubMed

23.

Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042–52.PubMedPubMedCentral

24.

Huang H, Benzonana LL, Zhao H, Watts HR, Perry NJ, Bevan C, et al. Prostate cancer cell malignancy via modulation of HIF-1alpha pathway with isoflurane and propofol alone and in combination. Br J Cancer. 2014;111(7):1338–49.PubMedPubMedCentral

25.

Sporn MB. The war on cancer. Lancet. 1996;347(9012):1377–81.PubMed

26.

Johnson JP. Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease. Cancer Metastasis Rev. 1991;10(1):11–22.PubMed

27.

Hardingham JE, Grover P, Winter M, Hewett PJ, Price TJ, Thierry B. Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress. Mol Med. 2015;21(Suppl 1):S25–31.PubMedPubMedCentral

28.

Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K, et al. Metaanalysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology. 2010;138(5):1714–26.PubMed

29.

Luo X, Zhao H, Hennah L, Ning J, Liu J, Tu H, et al. Impact of isoflurane on malignant capability of ovarian cancer in vitro. Br J Anaesth. 2015;114(5):831–9.PubMed

30.

Wu KC, Yang ST, Hsia TC, Yang JS, Chiou SM, Lu CC, et al. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. Anticancer Res. 2012;32(11):4833–42.PubMed

31.

Lirk P, Berger R, Hollmann MW, Fiegl H. Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro. Br J Anaesth. 2012;109(2):200–7.PubMed

32.

Lirk P, Hollmann MW, Fleischer M, Weber NC, Fiegl H. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro. Br J Anaesth. 2014;113(Suppl 1):i32–8.PubMed

33.

Ni C, Li C, Dong Y, Guo X, Zhang Y, Xie Z. Anesthetic Isoflurane Induces DNA Damage Through Oxidative Stress and p53 Pathway. Mol Neurobiol. 2017;54(5):3591–605.PubMed

34.

•• Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol. 2015;12(4):213–26 This review examines the factors present in the perioperative period that may predispose patients to cancer recurrence and metastasis and interventions that may decrease that risk.PubMedPubMedCentral

35.

Chen RM, Chen TG, Chen TL, Lin LL, Chang CC, Chang HC, et al. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann N Y Acad Sci. 2005;1042:262–71.PubMed

36.

Inada T, Hirota K, Shingu K. Intravenous anesthetic propofol suppresses prostaglandin E2 and cysteinyl leukotriene production and reduces edema formation in arachidonic acid-induced ear inflammation. J Immunotoxicol. 2015;12(3):261–5.PubMed

37.

Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999;80(6):880–8.PubMed

38.

Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res. 2012;72(6):1407–15.PubMed

39.

Desmond F, McCormack J, Mulligan N, Stokes M, Buggy DJ. Effect of anaesthetic technique on immune cell infiltration in breast cancer: a follow-up pilot analysis of a prospective, randomised, investigator-masked study. Anticancer Res. 2015;35(3):1311–9.PubMed

40.

Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97(5):1331–9.PubMed

41.

Shaashua L, Shabat-Simon M, Haldar R, Matzner P, Zmora O, Shabtai M, et al. Perioperative COX-2 and beta-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial. Clin Cancer Res. 2017;23(16):4651–61.PubMedPubMedCentral

Titel: Cancer Biology: a Primer for Perioperative Clinicians
verfasst von: Jonathan A. Wilks
Publikationsdatum: 01.12.2018
Verlag: Springer US
Erschienen in: Current Anesthesiology Reports / Ausgabe 4/2018
Elektronische ISSN: 2167-6275
DOI: https://doi.org/10.1007/s40140-018-0302-5

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Cancer Biology: a Primer for Perioperative Clinicians

Abstract

Purpose of Review

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Abstract

Purpose of Review

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Propofol (TIVA) Versus Volatile-Based Anesthetics: Is There Any Oncological Benefit?

Cancer Tsunami: Emerging Trends, Economic Burden, and Perioperative Implications

Organization of Multidisciplinary Cancer Care for the Surgical Patient: Role of Anesthesiologists

Perioperative Stress, Inflammation, and Cancer Progression: Opportunities for Intervention in Breast and Colorectal Cancer Surgery Utilizing Beta-Adrenergic Blockade and COX-2 Inhibition

Safety in Anesthesia: Latin American Perspective

New Cancer Therapies: Implications for the Perioperative Period

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS